name:-0.058665037155151
name:-0.013547897338867
name:-0.016411066055298
Niyikiza; Clet Patent Filings

Niyikiza; Clet

Patent Applications and Registrations

Patent applications and USPTO patent grants for Niyikiza; Clet.The latest application filed is for "methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan".

Company Profile
15.12.54
  • Niyikiza; Clet - Gulph Mills PA
  • Niyikiza; Clet - Conshocken PA
  • Niyikiza; Clet - Collegeville PA
  • Niyikiza; Clet - Indianapolis IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Methods for treating pancreatic cancer using combination therapies
Grant 11,369,597 - Bayever , et al. June 28, 2
2022-06-28
Alpha polyglutamated antifolates and uses thereof
Grant 11,344,628 - Niyikiza , et al. May 31, 2
2022-05-31
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20220096458 - Bayever; Eliel ;   et al.
2022-03-31
Gamma-d Polyglutamated Pemetrexed And Uses Thereof
App 20220088218 - NIYIKIZA; Clet ;   et al.
2022-03-24
Alpha Polyglutamated Pemetrexed And Uses Thereof
App 20220088219 - NIYIKIZA; Clet ;   et al.
2022-03-24
Gamma-d Polyglutamated Pemetrexed And Uses Thereof
App 20220088220 - NIYIKIZA; Clet ;   et al.
2022-03-24
Gamma Polyglutamated Pralatrexate And Uses Thereof
App 20210346294 - NIYIKIZA; Clet ;   et al.
2021-11-11
Alpha Polyglutamated Tetrahydrofolates And Uses Thereof
App 20210346381 - NIYIKIZA; Clet ;   et al.
2021-11-11
Alpha Polyglutamated Lometrexol And Uses Thereof
App 20210338675 - NIYIKIZA; Clet ;   et al.
2021-11-04
Carotenoid Compositions And Uses Thereof
App 20210283055 - NIYIKIZA; Clet ;   et al.
2021-09-16
Platinum Complexes And Uses Thereof
App 20210259970 - NIYIKIZA; Clet ;   et al.
2021-08-26
Gamma Polyglutamated Lometrexol And Uses Thereof
App 20210228581 - NIYIKIZA; Clet ;   et al.
2021-07-29
Gamma Polyglutamated Aminopterin And Uses Thereof
App 20210213019 - NIYIKIZA; Clet ;   et al.
2021-07-15
Alpha Polyglutamated Methotrexate And Uses Thereof
App 20210169887 - NIYIKIZA; Clet ;   et al.
2021-06-10
Alpha Polyglutamated Raltitrexed And Uses Thereof
App 20210169884 - NIYIKIZA; Clet ;   et al.
2021-06-10
Gamma Polyglutamated Pemetrexed And Uses Thereof
App 20210161899 - NIYIKIZA; Clet ;   et al.
2021-06-03
Targeted Liposomal Gemcitabine And Methods Thereof
App 20210154140 - NIYIKIZA; Clet ;   et al.
2021-05-27
Gamma Polyglutamated Methotrexate And Uses Thereof
App 20210154196 - NIYIKIZA; Clet ;   et al.
2021-05-27
Gamma Polyglutamated Tetrahydrofolates And Uses Thereof
App 20210128469 - NIYIKIZA; Clet ;   et al.
2021-05-06
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
Grant 10,980,795 - Bayever , et al. April 20, 2
2021-04-20
Targeted liposomal gemcitabine compositions and methods thereof
Grant 10,940,112 - Niyikiza , et al. March 9, 2
2021-03-09
Alpha Polyglutamated Aminopterin And Uses Thereof
App 20210052592 - NIYIKIZA; Clet ;   et al.
2021-02-25
Alpha Polyglutamated Antifolates And Uses Thereof
App 20210038719 - NIYIKIZA; Clet ;   et al.
2021-02-11
Gamma Polyglutamated Raltitrexed And Uses Thereof
App 20210023006 - NIYIKIZA; Clet ;   et al.
2021-01-28
Alpha Polyglutamated Pralatrexate And Uses Thereof
App 20200360390 - NIYIKIZA; Clet ;   et al.
2020-11-19
Gamma Polyglutamated Antifolates And Uses Thereof
App 20200360389 - NIYIKIZA; Clet ;   et al.
2020-11-19
Alpha Polyglutamated Pemetrexed And Uses Thereof
App 20200360388 - NIYIKIZA; Clet ;   et al.
2020-11-19
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
Grant 10,744,130 - Bayever , et al. A
2020-08-18
Polyglutamated Antifolates And Uses Thereof
App 20190307755 - NIYIKIZA; Clet ;   et al.
2019-10-10
Platinum Complexes And Uses Thereof
App 20190231690 - NIYIKIZA; CLET ;   et al.
2019-08-01
Alpha And Gamma-d Polyglutamated Antifolates And Uses Thereof
App 20190224334 - NIYIKIZA; Clet ;   et al.
2019-07-25
Methods For Treating Pancreatic Cancer Using Combination Therapies
App 20190117644 - Bayever; Eliel ;   et al.
2019-04-25
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20190117643 - Bayever; Eliel ;   et al.
2019-04-25
Alpha And Gamma-d Polyglutamated Antifolates And Uses Thereof
App 20180236098 - NIYIKIZA; Clet ;   et al.
2018-08-23
Methods for Treating Pancreatic Cancer Using Combination Therapies
App 20180008591 - Bayever; Eliel ;   et al.
2018-01-11
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20170368056 - Bayever; Eliel ;   et al.
2017-12-28
Targeted Liposomal Gemcitabine Compositions And Methods Thereof
App 20170319482 - NIYIKIZA; Clet ;   et al.
2017-11-09
Methods for treating pancreatic cancer using combination therapies
Grant 9,717,724 - Bayever , et al. August 1, 2
2017-08-01
Treatment Of Pancreatic Cancer With Liposomal Irinotecan
App 20170202840 - Bayever; Eliel ;   et al.
2017-07-20
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20170065578 - Bayever; Eliel ;   et al.
2017-03-09
Methods For Treating Pancreatic Cancer Using Combination Therapies
App 20170049768 - Bayever; Eliel ;   et al.
2017-02-23
Methods for Treating Pancreatic Cancer Using Combination Therapies
App 20160375004 - BAYEVER; ELIEL ;   et al.
2016-12-29
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
Grant 9,492,442 - Bayever , et al. November 15, 2
2016-11-15
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
Grant 9,452,162 - Bayever , et al. September 27, 2
2016-09-27
Liposome Encapsulated Affinity Drug
App 20160228573 - NIYIKIZA; Clet ;   et al.
2016-08-11
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20160228428 - Bayever; Eliel ;   et al.
2016-08-11
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
Grant 9,364,473 - Bayever , et al. June 14, 2
2016-06-14
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
Grant 9,339,497 - Bayever , et al. May 17, 2
2016-05-17
Methods for Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20160074382 - BAYEVER; ELIEL ;   et al.
2016-03-17
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20150374682 - BAYEVER; ELIEL ;   et al.
2015-12-31
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20150328156 - BAYEVER; ELIEL ;   et al.
2015-11-19
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20150182521 - Bayever; Eliel ;   et al.
2015-07-02
Methods For Preventing Toxic Drug-drug Interactions In Combination Therapies Comprising Anti-erbb3 Agents
App 20140234317 - Onsum; Matthew David ;   et al.
2014-08-21
Cancer Treatment Method
App 20130296261 - Buller; Richard ;   et al.
2013-11-07
Cancer Treatment Method
App 20130143834 - Buller; Richard ;   et al.
2013-06-06
Cancer Treatment Method
App 20110301185 - Buller; Richard ;   et al.
2011-12-08
Novel Antifolate Combination Therapies
App 20100210583 - Niyikiza; Clet
2010-08-19
Antifolate combination therapies
Grant 7,772,209 - Niyikiza August 10, 2
2010-08-10
Novel Antifolate Combination Therapies
App 20080032948 - Niyikiza; Clet ;   et al.
2008-02-07
Vitamin B12 and pemetrexed disodium combination therapies
Grant 7,053,065 - Niyikiza , et al. May 30, 2
2006-05-30
Novel antifolate combination therapies
App 20060079480 - Niyikiza; Clet
2006-04-13
Use of cisplatin in combination with folic acid for increasing cisplatin efficacy
App 20050220899 - Niyikiza, Clet
2005-10-06
Novel antifolate combination therapies
App 20030212038 - Niyikiza, Clet ;   et al.
2003-11-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed